Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $10
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.
Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.